SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-19-022393
Filing Date
2019-12-12
Accepted
2019-12-12 07:11:55
Documents
15
Period of Report
2019-12-11
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm   iXBRL 8-K 42784
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 244808
3 EXHIBIT 99.2 ex99_2.htm EX-99.2 289828
4 EXHIBIT 99.3 ex99_3.htm EX-99.3 314932
  Complete submission text file 0001140361-19-022393.txt   1181540

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ions-20191211.xsd EX-101.SCH 4198
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20191211_lab.xml EX-101.LAB 23692
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20191211_pre.xml EX-101.PRE 16832
14 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 4078
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 191281039
SIC: 2834 Pharmaceutical Preparations